SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-156858
Filing Date
2022-05-23
Accepted
2022-05-23 08:11:02
Documents
14
Period of Report
2022-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d350956d8k.htm   iXBRL 8-K 24066
2 EX-99.1 d350956dex991.htm EX-99.1 27157
6 GRAPHIC g350956g0523064705703.jpg GRAPHIC 2415
  Complete submission text file 0001193125-22-156858.txt   181249

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20220523.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20220523_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20220523_pre.xml EX-101.PRE 10830
8 EXTRACTED XBRL INSTANCE DOCUMENT d350956d8k_htm.xml XML 3201
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 22949627
SIC: 2836 Biological Products, (No Diagnostic Substances)